A Study to Demonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat Allergy

NCT06602726 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: REGN1908
DRUG: REGN1909
DRUG: Placebo

Sponsor

Regeneron Pharmaceuticals